Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets:
Cash and cash equivalents	$ 78	$ 349
Other assets	0	61
Total assets	78	410
Liabilities:
Accounts payable and accrued liabilities	3,225	1,484
Loan(s) payable - related party	3,198	0
Total liabilities	6,423	1,484
Commitments and contingencies (Note 6)
Stockholders' equity (deficit):
Common stock ($0.01 par value, 85,000 authorized in 2023 and 85,000 authorized in 2022, 46,410 issued and 40,738 outstanding in 2023 and 46,410 issued and 40,738 outstanding in 2022)	464	464
Additional paid-in capital	548,304	548,304
Accumulated deficit	(549,945)	(544,674)
Treasury stock, at cost - 2023 - 5,672 shares; and 2022 - 5,672 shares	(5,168)	(5,168)
Total stockholders' equity (deficit)	(6,345)	(1,074)
Total liabilities and stockholders' equity (deficit)	$ 78	$ 410